MANNELLI, FRANCESCO
MANNELLI, FRANCESCO
Medicina Sperimentale e Clinica
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease
2020 Loscocco G.G.; Mannelli F.; Mannelli L.; Vergoni F.; Gesullo F.; Rotunno G.; Guglielmelli P.; Vannucchi A.M.
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2013 Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A.
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2012 Mannelli F;Bencini S;Peruzzi B;Cutini I;Sanna A;Benelli M;Magi A;Gianfaldoni G;Rotunno G;Carrai V;Gelli AM;Valle V;Santini V;Notaro R;Luzzatto L;Bosi A
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial
2021 Mannelli, Francesco; Gianfaldoni, Giacomo; Guglielmelli, Paola; Buccisano, Francesco; Caporale, Roberto; Chiarini, Marco; Rossi, Giuseppe; Venditti, Adriano; Fazi, Paola; Crea, Enrico; Piciocchi, Alfonso; Voso, Maria Teresa; Vignetti, Marco; Amadori, Sergio; Vannucchi, Alessandro Maria
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
2022 Guglielmelli, Paola; Coltro, Giacomo; Mannelli, Francesco; Rotunno, Giada; Loscocco, Giuseppe G; Mannarelli, Carmela; Maccari, Chiara; Paoli, Chiara; Romagnoli, Simone; Bartalucci, Niccolò; Vannucchi, Alessandro M
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.
2012 Pagano L;Valentini CG;Pulsoni A;Fisogni S;Carluccio P;Mannelli F;Lunghi M;Pica G;Onida F;Cattaneo C;Piccaluga P;Di Bona E;Todisco E;Musto P;Spadea A;D'Arco A;Pileri S;Leone G;Amadori S;Facchetti F
BRAFV600E mutation in the wrong place: a case of concomitant polycythemia vera, hairy cell leukemia, and thyroid adenoma
2021 Loscocco G.G.; Rotunno G.; Mannelli L.; Mannelli F.; Vergoni F.; Guglielmelli P.; Vannucchi A.M.
CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease.
2011 Mannelli F;Gianfaldoni G;Intermesoli T;Cattaneo C;Borlenghi E;Cortelazzo S;Cavattoni I;Pogliani EM;Fumagalli M;Angelucci E;Romani C;Ciceri F;Corti C;Scattolin AM;Cortelezzi A;Mattei D;Audisio E;Spinelli O;Oldani E;Bosi A;Rambaldi A;Bassan R
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms
2020 Guglielmelli P.; Pacilli A.; Coltro G.; Mannelli F.; Mannelli L.; Contini E.; Rotunno G.; Bartalucci N.; Fiaccabrino S.; Sordi B.; Loscocco G.G.; Paoli C.; Vannucchi A.M.
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00.
2010 Bassan R;Rossi G;Pogliani EM;Di Bona E;Angelucci E;Cavattoni I;Lambertenghi-Deliliers G;Mannelli F;Levis A;Ciceri F;Mattei D;Borlenghi E;Terruzzi E;Borghero C;Romani C;Spinelli O;Tosi M;Oldani E;Intermesoli T;Rambaldi A
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
2021 Vannucchi A.M.; Sordi B.; Morettini A.; Nozzoli C.; Poggesi L.; Pieralli F.; Bartoloni A.; Atanasio A.; Miselli F.; Paoli C.; Loscocco G.G.; Fanelli A.; Para O.; Berni A.; Tassinari I.; Zammarchi L.; Maggi L.; Mazzoni A.; Scotti V.; Falchetti G.; Malandrino D.; Luise F.; Millotti G.; Bencini S.; Capone M.; Piccinni M.P.; Annunziato F.; Guglielmelli P.; Mannelli F.; Coltro G.; Fantoni D.; Borella M.; Ravenda E.; Peruzzi B.; Caporale R.; Cosmi L.; Liotta F.; Lombardelli L.; Logiodice F.; Vanni A.; Salvati L.; Lazzeri C.; Bonizzoli M.; Peris A.; Cianchi G.; Bosi A.; Pucatti M.; Fontanari P.; Benemei S.; MatucciCerinic M.; Turco L.
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis
2022 Loscocco, Giuseppe G; Santi, Raffaella; Carrai, Valentina; Coltro, Giacomo; Mannelli, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
2014 Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo, Alberto Bosi
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients
2012 B. Scappini; G. Gianfaldoni; F. Caracciolo; F. Mannelli; C. Biagiotti; C. Romani; EM. Pogliani; F. Simonetti; L. Borin; R. Fanci; I. Cutini; G. Longo; MC. Susini; E. Angelucci; A. Bosi
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.
2012 Scappini B;Gianfaldoni G;Caracciolo F;Mannelli F;Biagiotti C;Romani C;Pogliani EM;Simonetti F;Borin L;Fanci R;Cutini I;Longo G;Susini MC;Angelucci E;Bosi A
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
2022 Coltro, Giacomo; Mannelli, Francesco; Loscocco, Giuseppe Gaetano; Mannarelli, Carmela; Rotunno, Giada; Maccari, Chiara; Pancani, Fabiana; Atanasio, Alessandro; Vannucchi, Alessandro Maria; Guglielmelli, Paola
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.
2010 Gianfaldoni G;Mannelli F;Ponziani V;Longo G;Bencini S;Bosi A;Vannucchi AM
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.
2010 Gianfaldoni G; Mannelli F; Ponziani V; Longo G; Bencini S; Bosi A; Vannucchi AM.
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
2021 Cervantes F.; Ross D.M.; Radinoff A.; Palandri F.; Myasnikov A.; Vannucchi A.M.; Zachee P.; Gisslinger H.; Komatsu N.; Foltz L.; Mannelli F.; Passamonti F.; Gilotti G.; Sadek I.; Tiwari R.; Zor E.; Al-Ali H.K.
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
2020 Coltro, Giacomo; Mannelli, Francesco; Vergoni, Federica; Santi, Raffaella; Massi, Daniela; Siliani, Luisa Margherita; Marzullo, Antonella; Bonifacio, Stefania; Pelo, Elisabetta; Pacilli, Annalisa; Paoli, Chiara; Franci, Annalisa; Calabresi, Laura; Bosi, Alberto; Vannucchi, Alessandro Maria; Guglielmelli, Paola
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease | 2020 | Loscocco G.G.; Mannelli F.; Mannelli L.; Vergoni F.; Gesullo F.; Rotunno G.; Guglielmelli P.; Vannucchi A.M. | |
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2013 | Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A. | |
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2012 | Mannelli F;Bencini S;Peruzzi B;Cutini I;Sanna A;Benelli M;Magi A;Gianfaldoni G;Rotunno G;Carrai V;Gelli AM;Valle V;Santini V;Notaro R;Luzzatto L;Bosi A | |
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial | 2021 | Mannelli, Francesco; Gianfaldoni, Giacomo; Guglielmelli, Paola; Buccisano, Francesco; Caporale, Roberto; Chiarini, Marco; Rossi, Giuseppe; Venditti, Adriano; Fazi, Paola; Crea, Enrico; Piciocchi, Alfonso; Voso, Maria Teresa; Vignetti, Marco; Amadori, Sergio; Vannucchi, Alessandro Maria | |
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera | 2022 | Guglielmelli, Paola; Coltro, Giacomo; Mannelli, Francesco; Rotunno, Giada; Loscocco, Giuseppe G; Mannarelli, Carmela; Maccari, Chiara; Paoli, Chiara; Romagnoli, Simone; Bartalucci, Niccolò; Vannucchi, Alessandro M | |
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. | 2012 | Pagano L;Valentini CG;Pulsoni A;Fisogni S;Carluccio P;Mannelli F;Lunghi M;Pica G;Onida F;Cattaneo C;Piccaluga P;Di Bona E;Todisco E;Musto P;Spadea A;D'Arco A;Pileri S;Leone G;Amadori S;Facchetti F | |
BRAFV600E mutation in the wrong place: a case of concomitant polycythemia vera, hairy cell leukemia, and thyroid adenoma | 2021 | Loscocco G.G.; Rotunno G.; Mannelli L.; Mannelli F.; Vergoni F.; Guglielmelli P.; Vannucchi A.M. | |
CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease. | 2011 | Mannelli F;Gianfaldoni G;Intermesoli T;Cattaneo C;Borlenghi E;Cortelazzo S;Cavattoni I;Pogliani EM;Fumagalli M;Angelucci E;Romani C;Ciceri F;Corti C;Scattolin AM;Cortelezzi A;Mattei D;Audisio E;Spinelli O;Oldani E;Bosi A;Rambaldi A;Bassan R | |
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms | 2020 | Guglielmelli P.; Pacilli A.; Coltro G.; Mannelli F.; Mannelli L.; Contini E.; Rotunno G.; Bartalucci N.; Fiaccabrino S.; Sordi B.; Loscocco G.G.; Paoli C.; Vannucchi A.M. | |
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. | 2010 | Bassan R;Rossi G;Pogliani EM;Di Bona E;Angelucci E;Cavattoni I;Lambertenghi-Deliliers G;Mannelli F;Levis A;Ciceri F;Mattei D;Borlenghi E;Terruzzi E;Borghero C;Romani C;Spinelli O;Tosi M;Oldani E;Intermesoli T;Rambaldi A | |
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study | 2021 | Vannucchi A.M.; Sordi B.; Morettini A.; Nozzoli C.; Poggesi L.; Pieralli F.; Bartoloni A.; Atanasio A.; Miselli F.; Paoli C.; Loscocco G.G.; Fanelli A.; Para O.; Berni A.; Tassinari I.; Zammarchi L.; Maggi L.; Mazzoni A.; Scotti V.; Falchetti G.; Malandrino D.; Luise F.; Millotti G.; Bencini S.; Capone M.; Piccinni M.P.; Annunziato F.; Guglielmelli P.; Mannelli F.; Coltro G.; Fantoni D.; Borella M.; Ravenda E.; Peruzzi B.; Caporale R.; Cosmi L.; Liotta F.; Lombardelli L.; Logiodice F.; Vanni A.; Salvati L.; Lazzeri C.; Bonizzoli M.; Peris A.; Cianchi G.; Bosi A.; Pucatti M.; Fontanari P.; Benemei S.; MatucciCerinic M.; Turco L. | |
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis | 2022 | Loscocco, Giuseppe G; Santi, Raffaella; Carrai, Valentina; Coltro, Giacomo; Mannelli, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M | |
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. | 2014 | Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo, Alberto Bosi | |
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients | 2012 | B. Scappini; G. Gianfaldoni; F. Caracciolo; F. Mannelli; C. Biagiotti; C. Romani; EM. Pogliani; F. Simonetti; L. Borin; R. Fanci; I. Cutini; G. Longo; MC. Susini; E. Angelucci; A. Bosi | |
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. | 2012 | Scappini B;Gianfaldoni G;Caracciolo F;Mannelli F;Biagiotti C;Romani C;Pogliani EM;Simonetti F;Borin L;Fanci R;Cutini I;Longo G;Susini MC;Angelucci E;Bosi A | |
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis | 2022 | Coltro, Giacomo; Mannelli, Francesco; Loscocco, Giuseppe Gaetano; Mannarelli, Carmela; Rotunno, Giada; Maccari, Chiara; Pancani, Fabiana; Atanasio, Alessandro; Vannucchi, Alessandro Maria; Guglielmelli, Paola | |
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia. | 2010 | Gianfaldoni G;Mannelli F;Ponziani V;Longo G;Bencini S;Bosi A;Vannucchi AM | |
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia. | 2010 | Gianfaldoni G; Mannelli F; Ponziani V; Longo G; Bencini S; Bosi A; Vannucchi AM. | |
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study | 2021 | Cervantes F.; Ross D.M.; Radinoff A.; Palandri F.; Myasnikov A.; Vannucchi A.M.; Zachee P.; Gisslinger H.; Komatsu N.; Foltz L.; Mannelli F.; Passamonti F.; Gilotti G.; Sadek I.; Tiwari R.; Zor E.; Al-Ali H.K. | |
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature | 2020 | Coltro, Giacomo; Mannelli, Francesco; Vergoni, Federica; Santi, Raffaella; Massi, Daniela; Siliani, Luisa Margherita; Marzullo, Antonella; Bonifacio, Stefania; Pelo, Elisabetta; Pacilli, Annalisa; Paoli, Chiara; Franci, Annalisa; Calabresi, Laura; Bosi, Alberto; Vannucchi, Alessandro Maria; Guglielmelli, Paola |